Product Information
CLOMIPRAMINE 50 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2513 per EA under NDC 16571068409. Its NADAC has been published 288 times since Feb 17, 2021.
FDA first approved this application on Aug 7, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571068409
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212285FDA Approved
8/7/2020
TE Code
AB
On Market Since
11/1/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 50 MG CAPSULE has been published 288 times since Feb 17, 2021, and over the history we have for it it has declined 87.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2513 per EA |
|---|---|
| All-time high | $2.0285 (Mar 10, 2021) |
| All-time low | $0.2016 (May 22, 2024) |
| 52-week high | $0.2915 |
| 52-week low | $0.2257 |
| Median price | $0.3359 |
| Average price | $0.5857 |
| Largest weekly change | -56.5% (Nov 23, 2022) |
| Weeks tracked | 288 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 50 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.2513 per EA (NDC 16571068409), effective Aug 19, 2026.
How has the price of CLOMIPRAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has declined 87.6%. It has been tracked across 288 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 50 MG CAPSULE?
Since Feb 17, 2021, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has ranged from a low of $0.2016 (May 22, 2024) to a high of $2.0285 (Mar 10, 2021), with a median of $0.3359 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 50 MG CAPSULE?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOMIPRAMINE 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOMIPRAMINE 50 MG CAPSULE?
CLOMIPRAMINE 50 MG CAPSULE (NDC 16571068409) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.